Cargando…
Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy
Although 80% of individuals infected with the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) recover without antiviral treatments, the other 20% progress to severe forms of pulmonary disease, suggesting that the host’s immune response to the virus could influence the outcome of coronav...
Autor principal: | Shimizu, Yukihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723701/ https://www.ncbi.nlm.nih.gov/pubmed/33344582 http://dx.doi.org/10.12998/wjcc.v8.i23.5835 |
Ejemplares similares
-
Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus
por: Kotyla, Przemysław, et al.
Publicado: (2023) -
Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19
por: Chatterjee, Swapan K., et al.
Publicado: (2020) -
Host factors: Implications in immunopathogenesis of COVID-19
por: Jafarpour, Roghayeh, et al.
Publicado: (2021) -
Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19
por: Motallebnezhad, Morteza, et al.
Publicado: (2023) -
COVID-19: immunopathogenesis and Immunotherapeutics
por: Yang, Li, et al.
Publicado: (2020)